Literature DB >> 1780417

Serotonin 5-HT3 antagonists do not alter the discriminative stimulus properties of cocaine.

J M Paris1, K A Cunningham.   

Abstract

The central nervous system (CNS) of the rat is known to contain serotonin (5-HT) type -3 receptors (5-HT3). Behavioral evidence suggests that 5-HT3 receptors interact with mesolimbic dopamine (DA) systems and that 5-HT3 antagonists can interfere with the hyperlocomotive effects of amphetamine and cocaine and the rewarding and stimulus effects of morphine, nicotine and ethanol. Cocaine, which blocks the reuptake of DA, norepinephrine (NE), and 5-HT in the CNS, also may be an antagonist at 5-HT3 receptors. The purpose of the present study was to determine whether systemic administration of the 5-HT3 antagonists ICS 205930 or MDL 72222 could mimic or block the discriminative stimulus properties of cocaine. Once rats (N = 16) were trained to discriminate cocaine (10 mg/kg) from saline, substitution tests with various doses of cocaine (0.313-10 mg/kg), ICS 205930 (2-24 mg/kg), and MDL 72222 (2-16 mg/kg) were conducted. Cocaine produced a dose-related increase in cocaine-appropriate responding while the 5-HT3 antagonists engendered primarily saline-lever responding. Neither ICS 205930 nor MDL 72222 were able to antagonize the stimulus effects of cocaine (5 mg/kg). Response rates were not significantly reduced when the 5-HT3 antagonists were given in combination with cocaine. The results indicate that although 5-HT3 antagonists can inhibit some of the unconditioned behavioral effects of psychomotor stimulants, the discriminative stimulus effects of cocaine remain intact.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1780417     DOI: 10.1007/bf02245652

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  16 in total

1.  Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.

Authors:  A Butler; J M Hill; S J Ireland; C C Jordan; M B Tyers
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

2.  The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study.

Authors:  L H Jiang; C R Ashby; R J Kasser; R Y Wang
Journal:  Brain Res       Date:  1990-04-09       Impact factor: 3.252

3.  Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding.

Authors:  G J Kilpatrick; B J Jones; M B Tyers
Journal:  Nature       Date:  1987 Dec 24-31       Impact factor: 49.962

Review 4.  5-Hydroxytryptamine receptor subtypes.

Authors:  S J Peroutka
Journal:  Annu Rev Neurosci       Date:  1988       Impact factor: 12.449

5.  Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat.

Authors:  R M Hagan; B J Jones; C C Jordan; M B Tyers
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

6.  Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain.

Authors:  B K Koe
Journal:  J Pharmacol Exp Ther       Date:  1976-12       Impact factor: 4.030

7.  Blockade of serotonin receptors on autonomic neurones by (-)-cocaine and some related compounds.

Authors:  J R Fozard; A T Mobarok Ali; G Newgrosh
Journal:  Eur J Pharmacol       Date:  1979-11-16       Impact factor: 4.432

8.  Cocaine increases extracellular dopamine in rat nucleus accumbens and ventral tegmental area as shown by in vivo microdialysis.

Authors:  C W Bradberry; R H Roth
Journal:  Neurosci Lett       Date:  1989-08-14       Impact factor: 3.046

9.  Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release.

Authors:  E Carboni; E Acquas; R Frau; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1989-05-30       Impact factor: 4.432

10.  MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors.

Authors:  J R Fozard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-05       Impact factor: 3.000

View more
  10 in total

Review 1.  The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.

Authors:  A J Greenshaw; P H Silverstone
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

2.  Serotonin involvement in the discriminative stimulus effects of kappa opioids in pigeons.

Authors:  M E Bronson; Y P Lin; K Burchett; M J Picker; L A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  Effect of 5-HT3 receptor antagonists on the discriminative stimulus properties of morphine in rats.

Authors:  N Joharchi; E M Sellers; G A Higgins
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 4.  The role of serotonin in memory: interactions with neurotransmitters and downstream signaling.

Authors:  Mohammad Seyedabadi; Gohar Fakhfouri; Vahid Ramezani; Shahram Ejtemaei Mehr; Reza Rahimian
Journal:  Exp Brain Res       Date:  2014-01-16       Impact factor: 1.972

5.  The discriminative stimulus effects of methamphetamine in pigeons.

Authors:  J E Sasaki; T A Tatham; J E Barrett
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

6.  The effect of a 5-HT3 receptor antagonist, ondansetron, on brain stimulation reward, and its interaction with direct and indirect stimulants of central dopaminergic transmission.

Authors:  A M Montgomery; I C Rose; L J Herberg
Journal:  J Neural Transm Gen Sect       Date:  1993

Review 7.  Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse.

Authors:  R M Hagan; G J Kilpatrick; M B Tyers
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 8.  The role of 5-HT3 receptors in drug abuse and as a target for pharmacotherapy.

Authors:  E A Engleman; Z A Rodd; R L Bell; J M Murphy
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

9.  5-HT3 agonist-induced dopamine overflow during withdrawal from continuous or intermittent cocaine administration.

Authors:  G R King; Z Xue; C Calvi; E H Ellinwood
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

10.  Effects of dexfenfluramine and 5-HT3 receptor antagonists on stress-induced reinstatement of alcohol seeking in rats.

Authors:  Anh Dzung Lê; Douglas Funk; Stephen Harding; W Juzytsch; Paul J Fletcher; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2006-03-07       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.